These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21935898)

  • 21. A comparative high-throughput screening protocol to identify entry inhibitors of enveloped viruses.
    Wang J; Cheng H; Ratia K; Varhegyi E; Hendrickson WG; Li J; Rong L
    J Biomol Screen; 2014 Jan; 19(1):100-7. PubMed ID: 23821643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging intracellular receptors for hemorrhagic fever viruses.
    Jae LT; Brummelkamp TR
    Trends Microbiol; 2015 Jul; 23(7):392-400. PubMed ID: 26004032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Methanolic Extract of
    Kuo YT; Liu CH; Corona A; Fanunza E; Tramontano E; Lin LT
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus.
    Cui Q; Cheng H; Xiong R; Zhang G; Du R; Anantpadma M; Davey RA; Rong L
    Viruses; 2018 Nov; 10(12):. PubMed ID: 30513600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process.
    Salata C; Baritussio A; Munegato D; Calistri A; Ha HR; Bigler L; Fabris F; Parolin C; Palù G; Mirazimi A
    Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25933611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of Filovirus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus for Study of Filovirus Entry Mechanisms.
    Brouillette RB; Maury W
    Methods Mol Biol; 2017; 1628():53-63. PubMed ID: 28573610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor.
    Cheng H; Schafer A; Soloveva V; Gharaibeh D; Kenny T; Retterer C; Zamani R; Bavari S; Peet NP; Rong L
    Antiviral Res; 2017 Sep; 145():24-32. PubMed ID: 28645623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.
    Rathbun JY; Droniou ME; Damoiseaux R; Haworth KG; Henley JE; Exline CM; Choe H; Cannon PM
    J Virol; 2015 Aug; 89(16):8428-43. PubMed ID: 26041296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses.
    Mohr EL; McMullan LK; Lo MK; Spengler JR; Bergeron É; Albariño CG; Shrivastava-Ranjan P; Chiang CF; Nichol ST; Spiropoulou CF; Flint M
    Antiviral Res; 2015 Aug; 120():40-7. PubMed ID: 25986249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudotyped Viruses.
    Wang Y; Zhou Z; Wu X; Li T; Wu J; Cai M; Nie J; Wang W; Cui Z
    Adv Exp Med Biol; 2023; 1407():1-27. PubMed ID: 36920689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel cyclo-peptides inhibit Ebola pseudotyped virus entry by targeting primed GP protein.
    Li Q; Ma L; Yi D; Wang H; Wang J; Zhang Y; Guo Y; Li X; Zhou J; Shi Y; Gao GF; Cen S
    Antiviral Res; 2018 Jul; 155():1-11. PubMed ID: 29709562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.
    Yonezawa A; Cavrois M; Greene WC
    J Virol; 2005 Jan; 79(2):918-26. PubMed ID: 15613320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting.
    Millet JK; Tang T; Nathan L; Jaimes JA; Hsu HL; Daniel S; Whittaker GR
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30882796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A High-Throughput HIV-1 Drug Screening Platform, Based on Lentiviral Vectors and Compatible with Biosafety Level-1.
    Ellinger B; Pohlmann D; Woens J; Jäkel FM; Reinshagen J; Stocking C; Prassolov VS; Fehse B; Riecken K
    Viruses; 2020 May; 12(5):. PubMed ID: 32466195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of SARS-CoV entry--identification using an internally-controlled dual envelope pseudovirion assay.
    Zhou Y; Agudelo J; Lu K; Goetz DH; Hansell E; Chen YT; Roush WR; McKerrow J; Craik CS; Amberg SM; Simmons G
    Antiviral Res; 2011 Nov; 92(2):187-94. PubMed ID: 21820471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Establishment of a cell-based filovirus entry inhibitor evaluation system].
    Chen Q; Guo Y
    Yao Xue Xue Bao; 2015 Dec; 50(12):1538-44. PubMed ID: 27169274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lentiviral Vectors Pseudotyped with Filoviral Glycoproteins.
    Sinn PL; Coffin JE; Ayithan N; Holt KH; Maury W
    Methods Mol Biol; 2017; 1628():65-78. PubMed ID: 28573611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses.
    Lasala F; García-Rubia A; Requena C; Galindo I; Cuesta-Geijo MA; García-Dorival I; Bueno P; Labiod N; Luczkowiak J; Martinez A; Campillo NE; Alonso C; Delgado R; Gil C
    Antiviral Res; 2021 Feb; 186():105011. PubMed ID: 33428961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pseudotyped Virus for Henipavirus.
    Li T; Liang Z; Huang W; Wang Y
    Adv Exp Med Biol; 2023; 1407():175-190. PubMed ID: 36920697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry.
    Yermolina MV; Wang J; Caffrey M; Rong LL; Wardrop DJ
    J Med Chem; 2011 Feb; 54(3):765-81. PubMed ID: 21204524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.